Propanc Biopharma, Inc.
PPCB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $21 | $10 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $5 | $3 | $3 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8,335 | $1 | $6 | $9 |
| Total Curr. Assets | $8,353 | $25 | $19 | $15 |
| Property Plant & Equip (Net) | $59 | $18 | $39 | $65 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $11,220 | $29 | $2 | $2 |
| Total NC Assets | $11,279 | $47 | $41 | $67 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $19,632 | $72 | $60 | $82 |
| Liabilities | – | – | – | – |
| Payables | $1,250 | $1,213 | $967 | $943 |
| Short-Term Debt | $1,580 | $890 | $527 | $998 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2,749 | $1,690 | $1,665 | $1,122 |
| Total Curr. Liab. | $5,578 | $3,793 | $3,158 | $3,063 |
| LT Debt | $147 | $59 | $19 | $42 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $147 | $59 | $19 | $42 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $59 | $19 | $41 | $63 |
| Total Liabilities | $5,726 | $3,851 | $3,178 | $3,105 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $5 |
| Common Stock | $12 | $479 | $8 | $0 |
| Retained Earnings | -$125,622 | -$66,698 | -$64,685 | -$61,558 |
| AOCI | $1,319 | $1,270 | $1,295 | $1,235 |
| Other Equity | $138,197 | $61,171 | $60,265 | $57,294 |
| Total Equity | $13,906 | -$3,779 | -$3,117 | -$3,024 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $19,632 | $72 | $60 | $82 |
| Net Debt | $1,715 | $927 | $536 | $1,036 |